The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to show the effectiveness of PRO-513 for associated symptoms of nausea, photophobia, and phonophobia due to a migraine attack.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
650
Associated Neurologists of Southern CT
Fairfield, Connecticut, United States
New England Center for Headache
Stamford, Connecticut, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
LCFP Inc.
Fort Myers, Florida, United States
Palm Beach Neurological Center
Palm Beach Gardens, Florida, United States
Diamond Headache Clinic
Chicago, Illinois, United States
International Research Center
Towson, Maryland, United States
Michigan Head-Pain and Neurologic Institute
Ann Arbor, Michigan, United States
Mercy Health Research
St Louis, Missouri, United States
New York Headache Center
New York, New York, United States
Headache Wellness Center
Greensboro, North Carolina, United States
...and 6 more locations